Vivaldi Asset Management LLC bought a new stake in Novadaq Technologies Inc (NASDAQ:NVDQ) (TSE:NDQ) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 118,618 shares of the medical research company’s stock, valued at approximately $1,390,000. Vivaldi Asset Management LLC owned 0.21% of Novadaq Technologies as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Gamco Investors INC. ET AL bought a new stake in shares of Novadaq Technologies in the second quarter valued at about $145,000. Virtu Financial LLC bought a new stake in shares of Novadaq Technologies in the second quarter valued at about $157,000. Envestnet Asset Management Inc. boosted its position in shares of Novadaq Technologies by 12.9% in the first quarter. Envestnet Asset Management Inc. now owns 25,374 shares of the medical research company’s stock valued at $197,000 after acquiring an additional 2,898 shares during the period. GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in Novadaq Technologies during the second quarter worth about $255,000. Finally, US Bancorp DE lifted its position in Novadaq Technologies by 0.8% during the first quarter. US Bancorp DE now owns 46,899 shares of the medical research company’s stock worth $365,000 after purchasing an additional 362 shares during the period. 75.38% of the stock is owned by institutional investors.

Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada reaffirmed a “hold” rating and set a $11.75 price objective on shares of Novadaq Technologies in a research report on Friday. Zacks Investment Research raised shares of Novadaq Technologies from a “sell” rating to a “hold” rating in a research report on Friday, August 18th. Canaccord Genuity reaffirmed a “hold” rating and set a $11.75 price objective on shares of Novadaq Technologies in a research report on Friday. Northland Securities reaffirmed a “hold” rating and set a $11.75 price objective on shares of Novadaq Technologies in a research report on Monday, August 14th. Finally, JMP Securities reaffirmed a “market perform” rating on shares of Novadaq Technologies in a research report on Thursday, July 13th. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $11.86.

Novadaq Technologies Inc (NASDAQ:NVDQ) opened at 11.75 on Tuesday. The firm’s market cap is $679.41 million. The firm’s 50-day moving average price is $11.68 and its 200 day moving average price is $8.98. Novadaq Technologies Inc has a 52 week low of $5.84 and a 52 week high of $12.74.

WARNING: This report was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://theolympiareport.com/2017/09/05/vivaldi-asset-management-llc-invests-1-39-million-in-novadaq-technologies-inc-nvdq.html.

Novadaq Technologies Company Profile

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Institutional Ownership by Quarter for Novadaq Technologies (NASDAQ:NVDQ)

Receive News & Ratings for Novadaq Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.